Gs-441524
CAS No:
1191237-69-0
Molecular Formula：
C12H13N5O4
Molecular Weight：
291.26
Download Product Documents
Missing docs? Contact support.
Technical Data
| Appearance | White to off-white solid |
|---|---|
| Solubility | Soluble in dimethyl sulfoxide |
| Identification | HPLC,The principal peak in the chromatogram obtained with the test solution is similar inretention time to the principal peak in the chromatogram obtained with reference solution. |
| Related substances | alpha-Isomer≤0.10% |
| Loss on drying | ≤1.00% |
| Residue on ignition | ≤0.5% |
| Purity | >99.70% |
Description
GS-441524 is an adenosine nucleotide analog antiviral, similar to [remdesivir]. This molecule was patented in 2009. In vitro studies of GS-441524 have determined it has a higher EC50 than remdesivir against a number of viruses, meaning GS-441524 is less potent. GS-441524 continues to be studied in the treatment of Feline Infectious Peritonitis Virus, a coronavirus that only infects cats.
Safety Information
GHS
Pictogram:
Signal Word:
Danger
Hazard Statements:
H315 : Causes skin irritation
H317 : May cause an allergic skin reaction
H318 : Causes serious eye damage
H334 : May cause allergy or asthma symptoms or breathing difficulties if inhaled
H335 : May cause respiratory irritation
H341 : Suspected of causing genetic defects
H361 : Suspected of damaging fertility or the unborn child
H371 : May cause damage to organs
Precautionary Statements:
Prevention
P203: Obtain, read and follow all safety instructions before use.
P233: Keep container tightly closed.
P260: Do not breathe dust/fume/gas/mist/vapours/spray.
P261: Avoid breathing dust/fume/gas/mist/vapours/spray.
P264: Wash thoroughly after handling.
P264+P265: Wash thoroughly after handling. Do not touch eyes.
P270: Do not eat, drink or smoke when using this product.
P271: Use only outdoors or in a well-ventilated area.
P272: Contaminated work clothing should
not be allowed out of the workplace.
P280: Wear protective gloves/
protective clothing/eye protection/face protection.
P284: [In case of inadequate ventilation] wear respiratory protection.
Response
P302+P352: IF ON SKIN: Wash with plenty of soap and water.
P304+P340: IF INHALED: Remove person to fresh air and keep comfortable for breathing.
P305+P354+P338: IF IN EYES: Rinse cautiously with water for several minutes.
Remove contact lenses, if present and easy to do. Continue rinsing.
P308+P316: IF exposed or concerned: Get emergency medical attention immediately.
P317: Get medical help.
P318: IF exposed or concerned, get medical advice/attention.
P319: Get medical advice/attention if you feel unwell.
P332+P317: If skin irritation occurs: Get medical help.
P333+P317: If skin irritation or rash occurs: Get medical help.
P342+P316: If experiencing respiratory symptoms: Get emergency medical attention immediately.
P362+P364: Take off contaminated clothing and wash it before reuse.
Storage
P403: Store in a well-ventilated place.
P403+P233: Store in a well-ventilated place. Keep container tightly closed.
P405: Store locked up.
Disposal
P501: Dispose of contents/container in accordance with local/regional/national/international regulations.
References
Impact of remdesivir modifications on human HINT1 binding – A structural and functional study in the remdesivir activation pathway；Publication Name: Structure (London, England : 1993)；Publication Date: 2026-05-25；PMID: 42184828；DOI: 10.1016/j.str.2026.04.015
Efectividad y seguridad de remdesivir y nirmatrelvir-ritonavir en la COVID-19 leve-moderada en los servicios de urgencia hospitalaria españoles；Publication Name: Medicina Clínica；Publication Date: 2025-08；PMID: 40412101；DOI: 10.1016/j.medcli.2025.106912
Successful treatment of prolonged COVID-19 with remdesivir and nirmatrelvir/ritonavir in a patient with a history of diffuse large B-cell lymphoma: a case report；Publication Name: Journal of the Egyptian National Cancer Institute；Publication Date: 2025-06-30；PMID: 40583098；DOI: 10.1186/s43046-025-00291-1
Eco-friendly spectrofluorimetric determination of remdesivir in the presence of its metabolite in human plasma for therapeutic monitoring in COVID-19 patients；Publication Name: Scientific Reports；Publication Date: 2025-06-23；PMID: 40550830；DOI: 10.1038/s41598-025-05198-4
Pharmacokinetics and Metabolism of Broad-Spectrum Antivirals Remdesivir and Obeldesivir with a Consideration to Metabolite GS-441524: Same, Similar, or Different?；Publication Name: Viruses；Publication Date: 2025-06-10；PMID: 40573427；DOI: 10.3390/v17060836
Population Pharmacokinetic Modelling of Remdesivir and Its Metabolite GS-441524 in Hospitalised Patients with COVID-19；Publication Name: Clinical Pharmacokinetics；Publication Date: 2025-04-22；PMID: 40261493；DOI: 10.1007/s40262-025-01496-2
High‐dose induction therapy and treatment termination criteria for feline infectious peritonitis with remdesivir, GS‐441524 and adjunctive mefloquine: 46 cases (2023)；Publication Name: The Journal of small animal practice；Publication Date: 2025-04-18；PMID: 40251466；DOI: 10.1111/jsap.13869
Treatment of feline infectious peritonitis in cats with molnupiravir: clinical observations and outcomes for 54 cases；Publication Name: Australian Veterinary Journal；Publication Date: 2025-04-15；PMID: 40234239；DOI: 10.1111/avj.13433
Pharmacokinetics of GS‐441524 following intravenous remdesivir in six cats and results of therapeutic drug monitoring during treatment of feline infectious peritonitis: 22 cases (2021–2024)；Publication Name: The Journal of small animal practice；Publication Date: 2025-03-17；PMID: 40097914；DOI: 10.1111/jsap.13849
Remdesivir is active in vitro against tick-borne encephalitis virus and selects for resistance mutations in the viral RNA-dependent RNA polymerase；Publication Name: Infectious diseases (London, England)；Publication Date: 2025-02-20；PMID: 39973341；DOI: 10.1080/23744235.2025.2468510
Reviews
There are no reviews yet.